Skip to main content
. 2004 Oct 26;91(10):1763–1768. doi: 10.1038/sj.bjc.6602209

Table 3. Adverse event.

  Grade 2
Grade 3
Grade 4
Toxicity No (%) patients % cycles No (%) patients % cycles No (%) patients % cycles
Neutropenia 4 (19) 23 9 (43) 20 3 (14) 5
Thrombocytopenia 0 2 4 (19) 6 1 (5) 1
Anaemia 10 (38) 14 2 (10) 2 0 0
Infection 6 (29) 16 7 (33) 9 0 0
Palmar-plantar erythema 5 (24) 9 4 (19) 5 0 0
Diarrhoea 2 (10) 2 3 (14) 5 0 0
Nausea and vomiting 6 (29) 7 1 (5) 1 0 0
Lethargy 5 (24) 8 2 (10) 4 0 0
Thromboembolism 0 0 1 (5) 1 2 (10) 2
Skin rash 4 (19) 6 1 (5) 2 1 (5) 1
Haemorrhage 2 (10) 4 1 (5) 1 0 0
Dyspnoea 6 (29) 12 1 (5) 1 0 0
Mood alteration 0 1 1 (5) 1 0 0
Renal impairment 1 (5) 1 2 (10) 2 0 0
Hepatic dysfunction 1 (5) 2 1 (5) 1 0 0